Axio Biosolutions

Axio Biosolutions Deep science Medtech company with focus on Advanced Woundcare, Surgical Care, Military Medicine. Makers of , , + & SureKlot

Axio was founded in 2008 by Leo Mavely, a bioengineer to develop novel biopolymer platform based products for wound care. Axio has the distinction to be the first company from India to design, develop and commercialize an Emergency Haemostat for Trauma care. Controlling life-threatening bleeding continues to be the major cause of death from traumatic injuries. Axiostat® is its flagship product developed to reduce the mortality due to traumatic bleeding. Axio is a ISO 13485 certified company with an experienced team focused on bringing high-impact medical products to market. Specialties
Prehospital Wound care, Wound management, Biomaterials, Medical Devices

This Holi, we celebrate the hands that shape Axio’s journey, coloring it with passion, purpose, and pride.Each handprint...
03/03/2026

This Holi, we celebrate the hands that shape Axio’s journey, coloring it with passion, purpose, and pride.

Each handprint is more than just a mark, it represents teamwork, dedication, and a shared spirit that comes together to create meaningful impact.

Wishing you a vibrant and joyful Holi from all of us at Team Axio. 🌈✨

🎯Enforce Tac 2026: Where European Security Meets InnovationThree days. 1,000 exhibitors. 19,000 security professionals. ...
25/02/2026

🎯Enforce Tac 2026: Where European Security Meets Innovation

Three days. 1,000 exhibitors. 19,000 security professionals. Countless conversations that will shape the future of tactical medicine.

Our team spent three days in Nuremberg connecting with combat medics, defence procurement teams, and special forces units shaping the future of battlefield casualty care.

📩Missed us at the event? Let's talk about Axiostat Military for your procurement needs or partnership opportunities.

→ Email: Int.sales@axiobio.com

🎯We're at Enforce Tac 2026 | February 23-25, NurembergOur team will be on the ground at Europe's leading security and de...
23/02/2026

🎯We're at Enforce Tac 2026 | February 23-25, Nuremberg

Our team will be on the ground at Europe's leading security and defence platform to connect with the minds shaping tactical medicine and operational readiness.

🫱🏽‍🫲🏽Interested in connecting?
Let’s catch up over coffee and discuss our novel hemostatic solutions trusted by combat medics and tactical units for rapid hemorrhage control aiding in rapid bleeding control, will be there to assist you.

👇🏽Email us at int.sales@axiobio.com to schedule a one-on-one meeting.
📍Nuremberg | Feb 23-25, 2026

🏆 Certified for a sustainable future!Proud to announce our ISO 14001:2015 Environmental Management System & ISO 45001:20...
21/02/2026

🏆 Certified for a sustainable future!

Proud to announce our ISO 14001:2015 Environmental Management System & ISO 45001:2018 Occupational Health & Safety Management System certifications by SGS United Kingdom Ltd.

What this means:

🌱 Environmental protection at every step

👷‍♀️ Safe workplaces for our people

♻️ Reduced waste & optimized resources

🌍 Responsible manufacturing for global healthcare

Building innovative wound care solutions while protecting our planet and people.

Sustainable innovation. Responsible care.

13/02/2026

Thank you, WHX 2026.🫱🏽‍🫲🏽

Four days of innovation, collaboration, and meaningful connections have come to a close.

Thank you to the healthcare professionals, partners, and industry colleagues who took the time to explore how our 100% chitosan-based solutions - Axiostat and MaxioCel, can support better patient outcomes.

To continued collaboration and innovation ahead.

Day 2 at WHX and the conversations are just getting started. 🚀Yesterday, we witnessed incredible engagement from healthc...
11/02/2026

Day 2 at WHX and the conversations are just getting started. 🚀

Yesterday, we witnessed incredible engagement from healthcare professionals eager for practical solutions that deliver real results in critical care settings. Today, the momentum continues.

Still haven't visited us?

📍Booth NP2.D91 | Dubai Exhibition Centre
👉🏽Book a calendar slot with our team https://zurl.co/HyO6S

See you at the booth!

Axiostat MaxioCel

Here’s to partnerships that go beyond business.🥂Last night, we brought together partners from around the world to celebr...
10/02/2026

Here’s to partnerships that go beyond business.🥂

Last night, we brought together partners from around the world to celebrate shared successes, exchange clinical insights, and strengthen the partnerships that bring MaxioCel® and Axiostat® to patients who need them most.

Thank you to everyone who joined us. Your dedication to advancing wound care and saving lives inspires us every day.

Looking forward to achieving even more together in the year ahead. 🫱🏽‍🫲🏽

We’re live at WHX Dubai 2026.Axio Biosolutions is engaging with the global healthcare community around what truly matter...
09/02/2026

We’re live at WHX Dubai 2026.

Axio Biosolutions is engaging with the global healthcare community around what truly matters: proven science that delivers real patient outcomes.

At WHX, we are showcasing our FDA 510(k) cleared and CE certified chitosan-based* solutions designed for consistent performance across bleeding control and clinical wound care.

Axiostat®️
Chitosan hemostatic dressing designed to stop mild to severe bleeding within minutes in emergency, trauma, combat casualty, and vascular access.

MaxioCel®️
Advanced Chitosan woundcare designed to transform care in chronic and complex wounds such as Diabetic Foot Ulcers (DFUs), Pressure Ulcers, and Fungating wounds.

Built on 100% chitosan and proprietary technologies, our solutions reflect a focus on safety, consistency, and practical innovation clinicians rely on.

📍 Hall 6 | Booth NP2.D91
📅 WHX Dubai 2026, Dubai Exhibition Centre
👉🏽Book a calendar slot with our team- https://zurl.co/RnnoA


We're live at Hall 6, Booth NP2.D91, and it's been amazing connecting with healthcare professionals from around the worl...
09/02/2026

We're live at Hall 6, Booth NP2.D91, and it's been amazing connecting with healthcare professionals from around the world who share our passion for advancing patient care.

The next three days are packed with opportunities to explore how Axio Biosolutions is transforming bleeding control and wound care worldwide.

Haven't visited yet? We're ready for you!

📍Hall 6, Booth NP2.D91
📅Feb 9-12, 2026

👉🏽Book a calendar slot with our team https://zurl.co/RnnoA

See you tomorrow!

Axio Biosolutions Pvt. Ltd. is ready to welcome you at WHX Dubai 2026.Meet our team at WHX 2026 as we showcase our innov...
09/02/2026

Axio Biosolutions Pvt. Ltd. is ready to welcome you at WHX Dubai 2026.

Meet our team at WHX 2026 as we showcase our innovative portfolio of 100% chitosan-based hemostatic and wound care solutions, transforming patient care and setting new benchmarks in accessible healthcare worldwide.

📍 Hall 6, Booth NP2.D91 | Feb 9-12, 2026 | Dubai Exhibition Centre
👉🏽Book a calendar slot with our team https://zurl.co/o40lk

Innovation alone does not change patient outcomes. Proven science that clinicians can rely on does.At WHX 2026, Axio Bio...
07/02/2026

Innovation alone does not change patient outcomes. Proven science that clinicians can rely on does.

At WHX 2026, Axio Biosolutions stands apart by delivering solutions that work consistently, perform reliably, and reach patients where care matters most.

Built on 100 percent chitosan, our proprietary technologies are designed to deliver practical outcomes across combat casualty, emergency, trauma, and clinical wound care settings.

Two technologies. One purpose. Real-world impact.

• PBT® (Axiostat): Designed to stops mild to severe bleeding within minutes, without leaching or shedding. Dependable performance in emergency, trauma, combat casualty, and vascular access scenarios.

• BMG® technology (MaxioCel): Designed to effectively manages exudate while supporting an optimal healing environment across chronic and complex wounds.

Visit us at WHX 2026 and be part of the conversation shaping the future of bleeding control and wound care.

📍Hall 6 | Booth NP2.D91 | Dubai Exhibition Centre
📅Feb 9–12, 2026
🔗Book a meeting: https://zurl.co/3W4fV

As we get ready for MEDICA 2025, we’re bringing MaxioCel®, powered by patented BMG® Technology, designed to create an op...
13/11/2025

As we get ready for MEDICA 2025, we’re bringing MaxioCel®, powered by patented BMG® Technology, designed to create an optimal environment for wound betterment, leading to enhanced patient comfort.

The MaxioCel® wound care range offers a comprehensive approach to wound management and the treatment of chronic wounds such as Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers, and Fungating Wounds.

With its unique Chitosan Wound Dressing (CE and USFDA 510(k) cleared) and newly launched Wound Gel and Wound Irrigation Solution*, MaxioCel® provides clinicians with a complete wound care solution.

Its unique technology ensures superior exudate management, promotes faster granulation, and supports biofilm removal without inducing antimicrobial resistance (AMR).

📍Hall 6 Booth B16, Messe Düsseldorf, Germany
📅17–20 November 2025

To book an appointment, click on the link shared in the comments.

*Available in select markets

Address

Plot 18 Pharma Techno Park
Ahmedabad
382220

Opening Hours

Monday 9:30am - 6pm
Tuesday 9:30am - 6pm
Wednesday 9:30am - 6pm
Thursday 9:30am - 6pm
Friday 9:30am - 6pm
Saturday 9:30am - 3pm

Telephone

+918860786067

Website

Alerts

Be the first to know and let us send you an email when Axio Biosolutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Axio Biosolutions:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

TEAM AXIO

Wounds cause suffering, pain, long hospital stays, morbidity and even death. We started on the premise that most of these are preventable. We demonstrated that it is possible. We believe in solving such primal issues through innovative use of technology. We invent and create such tech. We do not follow. We lead.